stella
beta
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma — Stella
Recruiting
Back to Esophageal Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
View full record on ClinicalTrials.gov